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EXPERT REVIEWShould buttresses and sealants be used to manage pulmonary
parenchymal air leaks?Sunil Singhal, MD,a and Joseph B. Shrager, MDbAlthough the vast majority of air leaks after pulmonary
resection are of no major significance and resolve spontane-
ously after a day or so, some air leaks will persist. These pro-
longed air leaks, and the initial air leaks that lead to them,
have drawn substantial attention for a variety of reasons.
First, air leaks are associated with (and may cause) other car-
diopulmonary complications, thereby increasing the overall
morbidity associated with pulmonary resection. Second,
even in the absence of associated complications, an air
leak that lasts after a patient is otherwise ready for
discharge may prolong hospital stay, creating a substantial
economic impact.
Both industry and independent investigators have pro-
posed a variety of solutions to the problem of air leaks. We
and other coauthors recently reviewed the postoperative tech-
niques that might be used to reduce the duration of air leaks
andmade suggestions regarding the use of these techniques.1
A number of equally controversial intraoperative products
and maneuvers have been advocated to prevent or ameliorate
air leaks. These potential solutions include a variety of glues
and sealants designed to be applied to areas of leakage, but-
tressingmaterials for staple lines, and finally some traditional
surgical techniques. Multiple studies, including quite a few
randomized clinical trials, have been published in recent
years to evaluate these products and techniques.
Several issues, however, complicate the thought process
when deciding whether to use these products and tech-
niques. First, the data that have accumulated regarding their
effectiveness are often conflicting. Results that statistically
favor the use of a product may not demonstrate a sufficient
magnitude of benefit for clinical relevance. Second, the
data suffer from broader problems, such as the frequent fail-
ure to report on the outcome variable of most concern to
surgeons—the incidence of prolonged or complicated air
leak—and the general failure to focus study on high-risk
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1220 The Journal of Thoracic and Cardiovascular Surcommercial products to manage air leak add substantially
to the cost of an operation, few studies have reported on their
cost-effectiveness. Certainly, use of an expensive product
with marginal evidence of its effectiveness is in no one’s
best interest.
As a result of the controversy in this area, we embarked on
a review of the available literature. We sought to identify,
read, and evaluate all publications that address the 2 most
commonly used techniques in intraoperative air leak man-
agement: sealants and buttresses. This commentary and
our management suggestions (Table 1) are based on that
review and, to a lesser extent, on our personal experience.
We specifically focus here on air leaks arising from the
lung parenchyma—not bronchial dehiscence, for which
management is generally quite different. We define air
leak as any leakage of air from the lung that is detected as
a result of bubbles in a chest drainage system, progressive
subcutaneous emphysema, or an expanding pneumothorax.
BACKGROUND
Clinical Impact of Air Leaks
Several studies have demonstrated an association between
postoperative air leak and increased complications after lo-
bectomy. Brunelli and colleagues2 found that patients with
prolonged air leak had a dramatically greater rate of empy-
ema. Varela and associates3 found that prolonged air leak
was associated with greater pulmonary morbidity, including
atelectasis, pneumonia, and empyema. Okereke and col-
leagues4 found that any air leak at all was associated with
more complications, as did DeCamp and coworkers5 for
patients after lung volume reduction surgery (LVRS).
It has also been clearly demonstrated in multiple studies
that air leak increases both hospital stay and cost. Every study
in the routine lung resection population reporting hospital
stay or cost as a function of air leak has found a clear associ-
ation.2-4,6,7 These studies have found that air leak prolongs
hospital stay by between 4 and 13.1 days. In a study of
post-LVRS patients,5 mean hospital stay with air leak was
11.8 days, versus 7.6 days without air leak (P ¼ .0005).
Preoperative Risk Factors for Air Leaks
The most consistently identified risk factor for air leak is
chronic obstructive pulmonary disease (COPD). Many pul-
monary function test parameters that reflect severity of
COPD are associated with air leak, including reduced forced
expiratory volume in 1 second (FEV1),
6,8,9 both FEV1 and
ratio of FEV1 to forced vital capacity less than 70%.
10 and
ratio of FEV1 to forced vital capacity less than 50%.
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Singhal and Shrager Expert ReviewAbbreviations and Acronyms
COPD ¼ chronic obstructive pulmonary disease
FEV1 ¼ forced expiratory volume in 1 second
LVRS ¼ lung volume reduction surgeryPatients undergoing LVRS for severe emphysema are espe-
cially susceptible to air leak,5 as are those undergoing other
types of resection with FEV1 less than 35% of the predicted
value.12 It is our opinion that patients with COPD with pre-
dominant emphysema (bullous disease, fragile lung tissue)
are at greater risk for prolonged air leak than are those
with predominant chronic bronchitis.
Other risk factors convincingly associated with air leak in-
clude the presence of adhesions,8 upper lobectomy and bilo-
bectomy versus other lobectomies,8 lobectomy versus lesser
resections,9 and steroid use greater than 10 mg daily for lon-
ger than 1 month.9 The incidence of air leak is likely surgeon
dependent,4 and larger air leaks clearly carry a greater risk of
becoming prolonged air leaks.9 In the post-LVRS popula-
tion,5 risk factors for air leaks were found to be similar to
those after standard pulmonary resection, including severity
of emphysema, adhesions, and steroid use (inhaled). In the
quite different population of intubated patients undergoing
lung biopsy for adult respiratory distress syndrome, the
only multivariate predictor of air leak was peak airway pres-
sure. The risk of air leak was reduced by 42% for every 5-cm
H2O reduction in peak airway pressure.
13
THE EVIDENCE FOR STAPLE LINE BUTTRESSES
In the belief that many air leaks occur at and immediately
adjacent to the holes created by staples in lung tissue,
Cooper and colleagues14 first reported the use of bovine peri-
cardium to buttress staple lines during LVRS. Subsequently,
this technique has been extended to relatively less emphyse-
matous patients undergoing pulmonary resection.15 Several
other materials have also been used as buttresses, including
parietal pleura, polydioxane ribbon, polytetrafluoroethylene
felt, expanded polytetrafluoroethylene, and collagen
patches. Nonabsorbable materials carry the risk of inducing
granulomatous inflammation and bacterial colonization,
which has led to rare cases of metalloptysis, largely with
bovine pericardium.16-18
Four randomized studies have compared buttressed to
nonbuttressed stapling: 2 in the post-LVRS setting19,20 and
2 among unselected patients after lobectomy.21,22 We
briefly review these reports.
Pulmonary Resection in Patients Without Severe
Emphysema
In studies of patients undergoing routine lobectomy
(FEV1 70%–80% predicted), Venuta and associates
22The Journal of Thoracic and Car(n ¼ 30) demonstrated decreased air leak and shorter hospi-
tal stay with pericardial buttressing, whereas Miller and co-
workers21 (n ¼ 80) demonstrated reduced duration of air
leak (P ¼ .02) but no significant difference in hospital stay
(P ¼ .24). The trial of Venuta and associates22 was very
small and lacked the ideal control group with unbuttressed
gastrointestinal anastomosis stapler use. Although both
studies implied that buttressing slightly reduced duration
of air leak, the larger and better-controlled trial did not iden-
tify a clear-cut benefit of in terms of either hospital stay or
chest tube duration. Buttressing staples lines does add as
much as several hundred dollars to procedural costs. In light
of the increased costs and unclear benefits, we believe that
buttressing staple lines is not recommended for the routine
case of a patient with less than moderate emphysema.
Pulmonary Resection in Patients With Severe
Emphysema
Management of air leak is particularly challenging in
patients after LVRS. Although analysis of the National
Emphysema Treatment Trial data identified no benefit to
buttressing staple lines,5 this analysis was not randomized
on the basis of buttressing. Other groups, with randomized
study designs, have observed a benefit to reinforcing the sta-
ple line in patients undergoing LVRS for emphysema.
Two randomized trials in this high-risk population have
demonstrated a benefit from buttressing staple lines with bo-
vine pericardium.19,20 A 2-center study by Hazelrigg and
colleagues19 involving 123 patients undergoing unilateral
thoracoscopic LVRS showed significant decreases both in
the duration of postoperative air leak, chest drainage and
in hospital stay.19 Patients with buttressing had chest drains
removed 2.5 days sooner and were discharged from the hos-
pital 2.8 days sooner. Total hospital charges were similar,
because costs for the pericardial sleeves offset the savings
in hospital time.
A 3-center study by Stammberger and associates20 evalu-
ating bilateral thoracoscopic LVRS (n ¼ 65) showed signif-
icant decreases in the incidence of initial air leak (77% vs
39%), median duration of air leak (0 vs 4 days, P< .001),
and median drainage time (5 vs 7.5 days, P¼ .045). Hospital
stay was slightly but not statistically significantly shorter in
the group with buttressing (9.5 vs 12.0 days, P ¼ .14).
In conclusion, the evidence from limited randomized
studies suggests that using buttresses on staple lines in pa-
tients with emphysema undergoing nonanatomic pulmonary
resections, such as LVRS, reduces both the incidence and
the duration of air leak. This permits the earlier removal of
chest drains and likely shortens hospital stay. It is not clear,
however, that complicated, prolonged air leaks are reduced
by these buttresses, and no cost benefit of using buttressed
staple lines has been demonstrated, even in this high-risk
population. A decrease in the costs of the buttresses could
ultimately provide a cost advantage.diovascular Surgery c Volume 140, Number 6 1221
TABLE 1. Suggestions for intraoperative use of buttresses and
sealants
Class Recommendation Level of evidence
Use of staple line buttresses
I In performing lung volume reduction
surgery, buttressing staple lines is
recommended to prevent postoperative
air leaks.
B
IIa In performing anatomic pulmonary
resections in patients with severe
emphysema (forced expiratory volume in
1 second 50% predicted or gross
parenchymal destruction), it is
reasonable to buttress staple lines, but the
benefit remains unproven.
B
III In performing pulmonary resection in
patients with less than severe
emphysema, buttressing staple lines to
prevent postoperative air leaks is not well
established and, given the increased costs
of therapy, should be avoided.
B
Use of topical sealants
IIb Although incompletely evaluated in high-
risk subgroups, the use of topical sealants
has not consistently translated into
a shorter chest tube duration or stay.
Because the overall benefit of these
materials has not been demonstrated,
they should not be used on a routine
basis.
A
Classification of recommendations and quality of evidence are according to Sackett
and colleagues43 and the American College of Cardiology and American Heart Asso-
ciation Task Force for Practice Guidelines.44
Expert Review Singhal and ShragerThere are not sufficient data to provide a strong recom-
mendation regarding the use of staple line buttresses when
performing anatomic lobectomy or segmentectomy, even
in patients with severe emphysema. We believe, however,
that the benefit of buttressing staple lines in patients with
severe emphysema likely translates to situations in which
a surgeon is stapling incomplete interlobar fissures or inter-
segmental planes during lobectomy or segmentectomy.
THE EVIDENCE FOR TOPICAL SEALANTS
A variety of sealants have been developed in an effort to
solve the problem of air leak. These topical sealants are de-
signed to be applied over staple lines and other lung surfaces
with violation of the visceral pleura. Surgical sealants
appear, from the many studies that have described their
application, to be successful in reducing the percentage of
patients with a visible air leak at the conclusion of an oper-
ation. Studies have not, however, consistently shown that
sealants substantially reduce (1) duration of air leak, (2)
time to removal of chest drains, or (3) hospital stay (Table 2).
Belda-Sanchı´s and colleaguesl23 and Tambiah and col-
leagues24 performed comprehensive reviews of the literature1222 The Journal of Thoracic and Cardiovascular Surevaluating sealants during pulmonary resection in patients
with lung cancer. Typically, standard closure techniques
plus a sealant were compared with the same intervention
without a sealant. The 2010 report from Belda-Sanchı´s
and colleagues23 identified 12 randomized, controlled trials
with a total of 1097 patients.25-36 The 2007 review by
Tambiah and colleagues24 added 1 more study to that anal-
ysis.37 Several additional studies38-42 have been published in
this area since these 2 reviews.
These studies have described a variety of types of seal-
ants, ranging from fibrin- and thrombin-based products to
synthetic polymers and from sprays to gelatinous solutions
to moistened patches. There is a broad range in quality
and methodology among these trials. For example, in most
cases there was no standard definition of air leak, and no at-
tempt was made to quantify the degree of air leak in the peri-
operative period. In 3 trials, patients were randomly assigned
to treatment after checking for the presence of intraoperative
air leak, whereas in 9 trials glue was applied regardless of the
presence of air leak. These studies also present few data that
address costs.
Although 11 trials found that a significantly lower
percentage of patients had air leak at the conclusion of the
operation when sealants were used,25-27,29-33,36,37,40 most
of these trials did not demonstrate any reduction in the
time of chest drainage. The limiting factor in removing
chest drains in these patients was often the volume of fluid
drainage, rather than the presence of air leak. There were 4
exceptions to this general result.27,37,41,42 Similarly,
although there was a trend in most of the publications
toward a shortened hospital stay in the sealant group, only
3 studies demonstrate a significant reduction in hospital
stay25,37,42: 1 with a polymeric sealant (U.S. Patent No.
5583114),25 1 with TachoSil (Nycomed International Man-
agement GmbH, Zurich, Switzerland),42 and 1 with BioGlue
(CryoLife Inc, Kennesaw, Ga).37
Among patients with a postoperative air leak, regardless
of whether a surgical sealant had been used, there were re-
ductions in mean air leak duration in 4 of the trials.25,27,32,40
Interestingly, in Fabian and associates’ trial,27 the incidence
of prolonged air leak heavily favored sealants (2% vs 16%,
P ¼ .015). This important outcome measure was not,
however, reported for most trials.
None of the previously mentioned randomized studies in-
cluded subgroup analysis to evaluate the effectiveness of
sealants for air leaks of varying sizes. Similarly, none of
the studies were targeted at the patients at highest risk for
complicated or prolonged air leaks—those with advanced
emphysema—nor did any report results for subgroups of
patients with substantial emphysema. There are therefore in-
sufficient data available to determine whether there are spe-
cific subgroups of patients who would more clearly benefit
from the use of sealants. One small, randomized study of
sealants in patients with severe emphysema—but in thegery c December 2010
TABLE 2. Randomized, controlled trials evaluating surgical sealants for intraoperative air leaks










Allen et al25 U.S. Patent No. 5583114
(novel polymeric sealant)
148 77% vs 16% [2 vs 2] [6.8 vs 6.2] 6 vs 7
Belboul et al26 Vivostat (autologous
fibrin sealant)
40 20% vs 60% NA [1 vs 3] [4 vs 4.5]
Fabian et al27 Fibrin glue 100 34% vs 68% 1.1 vs 3.1 3.5 vs 5 [4.6 vs 4.9]
Fleisher et al28 Fibrin glue 28 NA [3.2 vs 3.3] [6.1 vs 5.9] [9.8 vs 11.5]
Lang et al29 TachoComb
(fleece-bound sealant)
189 34% vs 37% [1.7 vs 2] NA NA
Macchiarini et al30 Focal, Inc (fibrin glue) 26 0% vs 82% [1.9 vs 2.4] [6.1 vs 6.4] [13 vs 14]
Moser et al41 Vivostat (fibrin glue) 25 (bilateral) NA NA 2.8 vs 5.9 NA
Mouritzen et al31 Fibrin glue 114 39% vs 66% [4 vs 5] [3 vs 4] [9 vs 10]
Porte et al32 Advaseal (polymeric sealant) 120 Data not provided* 1.4 vs 2.6 NA [9.2 vs 8.6]
Tansley et al37 BioGlue 52 53 vs 96% 1 vs 4 4 vs 5 6 vs 7
Wain et al33 Focal Seal (polyethylene
glycol-based gel)
172 8% vs 71% 1.3 vs 2.2 [4.5 vs 5.2] [7.4 vs 10.1]
Wong and Goldstraw34 Tisseal (fibrin glue) 66 NA [5 vs 4] [6 vs 6] [8 vs 9]
Wurtz et al35 Fibrin glue 50 * NA NA [11.4 vs 13]
Wurtz et al36 Fibrin glue 50 * NA NA [9.9 vs 10.6]
Anegg et al42 Tachosil (fleece-bound
sealing)
173 NA Data not provided* 5.1 vs 6.3 6.2 vs 7.7
D’Andrilli et al40 Polymeric sealant 203 15% vs 41% 3.5 vs 4.2 NA [5.7 vs 6.2]
Unbracketed values indicate significant difference (P<.05); bracketed values indicate difference not reaching significance. NA, Not available (not assessed or published). Vivostat
is manufactured by Vivostat A/S, Alleroed, Denmark; TachoComb is manufactured by Nycomed International Management GmbH, Zurich, Switzerland; Focal Inc, Lexington,
Mass; Advaseal is manufactured by Ethicon Inc, Johnson & Johnson Medical, Somerville, NJ; BioGlue is manufactured by CryoLife Inc, Kennesaw, Ga; Focal Seal is manufac-
tured by Focal Inc; Tisseal is manufactured by Baxter Healthcare Corp, Deerfield, Ill; and Tachosil is manufactured by Nycomed International Management GmbH. *Significant
improvement reported (but raw data not provided) for treated group versus untreated group.
Singhal and Shrager Expert Reviewsetting of LVRS—has been published. In this study of 25 pa-
tients undergoing bilateral thoracoscopic LVRS, autologous
fibrin sealant was applied to the staple line on 1 side of the
chest only.41 Both the incidence of prolonged air leak and
mean duration of drainage were significantly reduced on
the sealant side (4.5% and 2.8 days vs 31.8% and 5.9
days, respectively).
There have been recent reports that a particular type of
sealant combined with electrocautery dissection of fissures
may be superior to the use of stapler devices. A randomized
trial of 60 patients with COPD (FEV1 65%) reported that
collagen patches coatedwith human fibrinogen and thrombin
(TachoSil) after electrocautery dissection reduced duration
of chest tube drainage (3.5 vs 5.9 days, P ¼ .0021) and hos-
pital stay (5.9 vs 7.5 days, P ¼ .01) relative to stapling.39 In
another study with 40 randomly assigned patients, there was
a reduction in the duration of air leak in the electrocautery
plus patch group (1.7 vs 4.5 days, P ¼.003). This relatively
new concept of using electrocautery dissection plus sealants
might even provide a cost benefit, because it would eliminate
the significant costs associated with stapling devices.
To summarize the sealant data, most sealants appear to re-
duce the percentage of patients with a visible air leak present
at the end of an operation. The vast majority of these seal-
ants, however, do not appear to alter duration of air leak orThe Journal of Thoracic and Carduration of chest tube drainage to a clinically significant de-
gree (and, for the most part, not even to a statistically signif-
icant degree). Only 4 of 16 randomized studies showed
significantly shortened hospital stays in the sealant group,
and only 2 studies clearly showed the reduced air leak and
chest tube durations that one might expect to result in this
shortened hospital stay. Many of the studies have not report
on whether the sealants reduced complicated or prolonged
air leak, the outcome variable that is perhaps most important.
Finally, only a single study of a liquid sealant applied the
product to the group at highest risk, those with substantial
emphysema. That study showed a benefit for its sealant (au-
tologous fibrin), giving us a hint that perhaps sealants—like
buttresses—might be appropriately applied to selected
patients with substantial emphysema.
In light of these inconclusive results across sealant studies
and the significantly increased costs that would be incurred
by using sealants indiscriminately, it would seem appropriate
to use sealants only very selectively at this point. Although
our ‘‘gut feeling’’ is that patients with at least moderately se-
vere emphysema undergoing lobectomy may well benefit
from the use of sealants on large leaks, such a recommenda-
tion has not been securely established by the data.
There remains, then, a substantial need for randomized
studies that either evaluate sealants in patients undergoingdiovascular Surgery c Volume 140, Number 6 1223
Expert Review Singhal and Shragerlobectomy who have at least moderate emphysema or are
large enough for stratification of results on the basis of de-
gree of emphysema. Similarly, studies large enough for
stratification on the basis of the size of the intraoperative
air leak would represent substantial contributions, as would
more studies that look at prolonged air leak as a primary out-
come measure. The most recent data in support of managing
incomplete fissures with cautery plus collagen fleece–bound
sealants instead of staplers are promising, but the issue
requires further study.
OTHERWELL-SUPPORTED TECHNIQUES
Although a full discussion is beyond the length limitations
of this commentary, it must be mentioned that there are 2 tra-
ditional techniques of reducing air leaks that have support
from prospective, randomized studies in the literature. These
include creation of an apical pleural tent after upper lobec-
tomy or upper bilobectomy (2 randomized trials with posi-
tive results)45,46 and creation of pneumoperitoneum after
lower bilobectomy (1 randomized trial with positive
results).47 These techniques are safe and highly effective,
and they have essentially zero cost. They are probably
underutilized by surgeons.
CONCLUSIONS
The use of many of the intraoperative techniques that are
available to prevent or reduce air leaks has been driven by
aggressive marketing by industry of commercially available
sealants and staple line buttresses. The appeal of these seal-
ants and buttresses lies in their ease and speed of use. Their
costs are sufficiently high, however, that they should be used
only if they provide clear clinical benefits.
Buttresses have been shown in randomized trials to re-
duce the incidence and duration of air leak and to reduce
the time that tube drainage is required in patients with severe
emphysema undergoing nonanatomic resections. Although
the data are not clear for patients with severe emphysema
undergoing anatomic lobectomy and segmentectomy, we
believe that it is reasonable to use staple-line buttresses in
these patients as well.
With regard to liquid sealants, most studies have reported
neither statistically nor clinically significant improvements
in hospital stay or time to removal of chest tube. Although
one might think it logical that sealants would demonstrate
clearer benefits in patients with substantial emphysema,
this may not be the case, and only a single small study (albeit
with positive results) has looked at this subgroup of patients.
Also needed are studies that are large enough for stratifica-
tion on the basis of the size of the initial intraoperative air
leaks, more studies that look at prolonged or complicated
air leak as an outcome measure, and more studies that eval-
uate costs. We believe that on the basis of current data, seal-
ants should not be used routinely, and hospitals and insurers
may be justified in questioning their use on cost/benefit1224 The Journal of Thoracic and Cardiovascular Surgrounds. The more traditional and relatively cost-free
techniques—pleural tenting and pneumoperitoneum—are
probably underutilized for high-risk patients.References
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